Business Context and Reporting Period
Company: The Clorox Company
Filing Type: Form 8-K (Current Report)
Date of Report: July 18, 2011
Event: Adoption of a shareholder rights plan (poison pill) and declaration of a dividend of preferred share purchase rights.
Key Financial Metrics
This filing is a current report regarding corporate governance and capital structure changes. It does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes
The Board of Directors declared a dividend of one preferred share purchase right (a "Right") for each outstanding share of common stock. This action materially modifies the rights of security holders to protect against coercive or unfair takeover tactics.
- Trigger Threshold: Rights become exercisable if any person or group acquires 10% or more of the outstanding common stock without Board approval.
- Penalty Mechanism: Upon triggering, non-acquiring shareholders may purchase Company common stock (Flip-In) or acquiring corporation stock (Flip-Over) with a market value of $700 for an exercise price of $350.
- Expiration: The Rights will expire on July 16, 2012.
- Redemption: The Board may redeem the Rights for $0.001 per Right at any time before an Acquiring Person emerges.
Guidance, Outlook, and Risks
Management Commentary: The Rights Agreement is designed to protect stockholders from coercive takeover tactics while not interfering with mergers or business combinations approved by the Board of Directors.
Risks and Contingencies: The primary contingency is the potential activation of the rights plan if an unsolicited acquirer crosses the 10% ownership threshold. The filing notes that synthetic interests created by derivative positions are treated as beneficial ownership for the purpose of triggering the plan, with exceptions for unassociated swap dealers.
Investor Verification Checklist
- Verify the record date for the Rights dividend (July 28, 2011) and the payable date (July 28, 2011).
- Confirm the expiration date of the Rights Agreement (July 16, 2012).
- Review the full Rights Agreement (Exhibit 4.1) for specific definitions of "Acquiring Person" and derivative treatment.
- Check the Certificate of Designations (Exhibit 3.1) for details on the Series A Junior Participating Preferred Stock.